Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and Tuberculosis
Status:
Completed
Trial end date:
2006-04-06
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to assess the safety and efficacy of interferon-gamma by
subcutaneous injection in complex treatment of patients with co-infection of HIV and
pulmonary tuberculosis and to determine the rational of its use.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
SPP Pharmaclon Ltd.
Collaborator:
North-Western State Medical University named after I.I.Mechnikov